2m 2m 2m 2m 2m 2m 2m
Cell Source (CLCS)
OTC
$0.89+$0.04 (+4.71%)
Price as of Jul 31, 2026- $60.5MMarket Cap
- 89.36%1-Year Change
- BiotechnologyIndustry
Cell Source (CLCS)
$0.89+$0.04 (+4.71%)
CLCS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.89 | ||
Change | +$0.04 (+4.71%) | ||
Open | $0.57 | ||
High | $0.89 | ||
Low | $0.57 | ||
Previous Close | $0.85 | ||
Volume | 250 | ||
30-Day Average Volume | 2,990 | ||
1-Week Change | 36.92% | ||
1-Month Change | 14.43% | ||
1-Year Change | 89.36% | ||
3-Year Change | 42,280.95% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.9M | ||
Total Assets | $292,446.00 | ||
Market Cap | $60.5M | ||
Enterprise Value | $63.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$600,391.00 | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | -$4.5M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | -22 | ||
PEG | 11 | ||
Price/Free Cash Flow | -101 | ||
Price/Operating Cash Flow | -101 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||